The Necker–Enfants Malades Hospital is a French teaching hospital in the 15th arrondissement of Paris. It is a hospital of the Assistance Publique – Hôpitaux de Paris group and is affiliated to the University of Paris Descartes.

There are 600 beds in Service de maladies infectieuses et tropicales, Hôpital Necker, APHP.

During the past decade, Service de maladies infectieuses et tropicales, Hôpital Necker, APHP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service de maladies infectieuses et tropicales, Hôpital Necker, APHP" #1 collaborator was "Chiron Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Service de maladies infectieuses et tropicales, Hôpital Necker, APHP" are "HIV Infections" (2 trials), "Infective Endocarditis" (2 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "Service de maladies infectieuses et tropicales, Hôpital Necker, APHP" in a lesser frequency.

Most popular intervention types in "Service de maladies infectieuses et tropicales, Hôpital Necker, APHP" are "Drug" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alendronate" (1 trials), "Amoxicillin" (1 trials), "Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine" (1 trials), "Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin" (1 trials) and "Interleukin-2 (IL-2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de maladies infectieuses et tropicales, Hôpital Necker, APHP" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Service de maladies infectieuses et tropicales, Hôpital Necker, APHP". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Service de maladies infectieuses et tropicales, Hôpital Necker, APHP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service de maladies infectieuses et tropicales, Hôpital Necker, APHP, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".